198 related articles for article (PubMed ID: 345134)
1. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
[No Abstract] [Full Text] [Related]
2. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
Stankler L
Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
[No Abstract] [Full Text] [Related]
3. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
[TBL] [Abstract][Full Text] [Related]
4. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
Gomez EC; Kaminester L; Frost P
Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two application schedules for clobetasol 17 propionate.
vd Harst LC; de Jonge H; Pot F; Polano MK
Acta Derm Venereol; 1982; 62(3):270-3. PubMed ID: 6179380
[No Abstract] [Full Text] [Related]
6. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
Eriksen K
Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
[TBL] [Abstract][Full Text] [Related]
7. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").
Svartholm H; Larsson L; Frederiksen B
Curr Med Res Opin; 1982; 8(3):154-7. PubMed ID: 6751703
[TBL] [Abstract][Full Text] [Related]
8. Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses.
Gip L; Hamfelt A
Cutis; 1984 Feb; 33(2):215-7, 220-2, 224. PubMed ID: 6365474
[TBL] [Abstract][Full Text] [Related]
9. Clobetasol--a potent new topical corticosteroid.
Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
[No Abstract] [Full Text] [Related]
10. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Jacobson C; Cornell RC; Savin RC
Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
[TBL] [Abstract][Full Text] [Related]
11. Comparison of betamethasone dipropionate lotion with salicylic acid (Diprosalic) and clobetasol propionate lotion (Dermovate) in the treatment of psoriasis of the scalp.
Hillström L; Pettersson L; Svensson L
J Int Med Res; 1982; 10(6):419-22. PubMed ID: 7152080
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids.
Walsh P; Aeling JL; Huff L; Weston WL
J Am Acad Dermatol; 1993 Sep; 29(3):501-3. PubMed ID: 8349876
[No Abstract] [Full Text] [Related]
13. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
[No Abstract] [Full Text] [Related]
14. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Serup J; Holm P
Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
[TBL] [Abstract][Full Text] [Related]
15. A double-blind comparison between a new trihalogenated dermatocorticosteroid (halometasone) cream and clobetasol 17-propionate (Dermovate) cream.
Schwarz KJ; Konzelmann M; Yawalkar SJ; Schoenenberger PM
Br J Clin Pract; 1982 May; 36(5):192-6. PubMed ID: 6756453
[No Abstract] [Full Text] [Related]
16. Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
Katz HI; Hien NT; Prawer SE; Mastbaum LI; Mooney JJ; Samson CR
J Am Acad Dermatol; 1987 Apr; 16(4):804-11. PubMed ID: 3553247
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
Stein L
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
[TBL] [Abstract][Full Text] [Related]
18. [Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
Blum G; Kröpfli P; Küng D; Suter H
Ther Umsch; 1984 Jun; 41(6):420-4. PubMed ID: 6379974
[No Abstract] [Full Text] [Related]
19. [Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
Rozman TA; Wiedey KD; Renovanz HD
Z Hautkr; 1983 Mar; 58(6):398-409. PubMed ID: 6342288
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of clobetasol dipropionate and betamethasone dipropionate].
Rozzoni M; Tribbia G; Reseghetti A; Bassi R
G Ital Dermatol Venereol; 1982; 117(5):LXV-LXIX. PubMed ID: 6764916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
